Raras
Buscar doenças, sintomas, genes...
Atrofia cerebral autossômica recessiva
ORPHA:363969CID-10 · G31.8DOENÇA RARA

Ataxia Espinocerebelar, também conhecida como Atrofia Espinocerebelar ou Degeneração Espinocerebelar corresponde a um grupo de doenças genéticas caracterizadas por sinais e sintomas referentes ao cerebelo, tronco cerebral, medula espinhal e nervos periféricos, assim como outras regiões do cérebro em diferentes subtipos. Patologicamente, são caracterizadas por perda neuronal nas áreas afetadas da substância cinzenta do cérebro e degenerações secundárias dos tractos da substância branca.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença rara autossômica recessiva caracterizada por atrofia cerebral progressiva. Associada a mutações no gene TMPRSS4, causa danos neurológicos.

Publicações científicas
11 artigos
Último publicado: 2024 Mar 29

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
4
pacientes catalogados
Início
Infancy
+ neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: G31.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Características mais comuns

Atrofia cerebral
1sintomas
Sem dados (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 1 características clínicas mais associadas, ordenadas por frequência.

Atrofia cerebralCerebral atrophy

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa33desde 1993
Total histórico11PubMed
Últimos 10 anos200publicações
Pico202463 papers
Linha do tempo
2000201020201993Hoje · 2026🧪 2010Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal recessive.

TMPRSS4Transmembrane protease serine 4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plasma membrane-anchored serine protease that directly induces processing of pro-uPA/PLAU into the active form through proteolytic activity (PubMed:24434139). Seems to be capable of activating ENaC (By similarity) (Microbial infection) In gut epithelial cells, facilitates human coronavirus SARS-CoV-2 infection through, at least, the cleavage of coronavirus spike glycoproteins which activates the glycoprotein for host cell entry

LOCALIZAÇÃO

Cell membraneSecreted

EXPRESSÃO TECIDUAL(Tecido-específico)
Esôfago - Mucosa
72.7 TPM
Cólon transverso
32.2 TPM
Intestino delgado
13.7 TPM
Vagina
13.3 TPM
Rim - Medula
8.0 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
autosomal recessive cerebral atrophy
HGNC:11878UniProt:Q9NRS4

Medicamentos aprovados (FDA)

1 medicamento encontrado nos registros da FDA americana.

💊 Penicillamine (PENICILLAMINE)
Ver no DailyMed/FDA

Variantes genéticas (ClinVar)

28 variantes patogênicas registradas no ClinVar.

🧬 TMPRSS4: GRCh37/hg19 11q23.3-24.2(chr11:115887338-126148523)x3 ()
🧬 TMPRSS4: GRCh37/hg19 11q23.3-25(chr11:116683755-134937416)x3 ()
🧬 TMPRSS4: Single allele ()
🧬 TMPRSS4: GRCh37/hg19 11p13-q25(chr11:32799481-134938470)x3 ()
🧬 TMPRSS4: GRCh37/hg19 11q23.1-24.3(chr11:112375478-128785742)x3 ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico5
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 5 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Atrofia cerebral autossômica recessiva

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

4 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Case Report: Ataxia telangiectasia with severe hemorrhagic cystitis.

Frontiers in pediatrics2026

Ataxia telangiectasia (AT) is a rare autosomal recessive genetic disorder caused by variants in the ataxia-telangiectasia mutated (ATM) gene. AT is characterized by progressive cerebellar degeneration, telangiectasia, immunodeficiency, cancer susceptibility, and radiosensitivity. This report presents a case of classic AT complicated by severe hemorrhagic cystitis, a rare clinical manifestation. Genetic analysis revealed novel variants in the ATM gene. A 12-year-old Han Chinese boy presented with recurrent gross hematuria that progressed in frequency and severity after completion of chemotherapy for T-cell acute lymphoblastic leukemia (ALL). He had developed gait instability at age 2, and brain MRI showed cerebellar atrophy. Genetic testing revealed compound heterozygous ATM variants: c.8357G>T (p.Gly2786Val) (maternal) and IVS54+3A>C (paternal) (NM_000051). Cystoscopy revealed multiple telangiectatic lesions of the bladder mucosa with associated yellow-brown sedimentation. Emergency cystoscopic electrocoagulation controlled the bleeding. We report two novel ATM variants (c.8357G>T, IVS54+3A>C) in a patient with classic AT who developed severe hemorrhagic cystitis associated with bladder wall telangiectasia. AT patients may be at risk for delayed, potentially life-threatening hemorrhagic cystitis, particularly following cyclophosphamide exposure. Cystoscopy is essential for diagnosis and enables timely endoscopic management. Mitochondrial short-chain enoyl-CoA hydratase deficiency (ECHS1D) represents a clinical spectrum in which several phenotypes have been described. Individuals with ECHS1D can present as neonates with hypotonia, dilated cardiomyopathy, severe developmental delay, seizures, sensorineural hearing loss, and severe lactic acidosis. More commonly, individuals present in infancy with developmental delay or regression, dystonia, hypotonia, ophthalmologic manifestations, sensorineural hearing loss, epilepsy, and feeding difficulties. In the late-onset form, individuals primarily present with paroxysmal dystonia that may be exacerbated by illness or exertion, subtle axial hypotonia, sensorineural hearing loss, and learning differences or normal development. T2 hyperintensity in the basal ganglia is very common in all individuals with ECHS1D and may affect any part of the basal ganglia. Prognosis is dependent on age of onset. In the neonatal form, clinical manifestations typically progress quickly, and infants succumb to central apnea or arrhythmia often consequent to overwhelming metabolic acidosis. The diagnosis of ECHS1D is established in a proband with characteristic findings and biallelic pathogenic variants in ECHS1 identified by molecular genetic testing. Targeted therapies: Valine-restricted diet; N-acetylcysteine Supportive care: Treatment of severe metabolic acidosis with bicarbonate therapy; hyperammonemia may be addressed by treatment of metabolic acidosis and/or consideration of hemodialysis. Standard treatment for developmental delay, seizures, spasticity, cardiomyopathy, pulmonary hypertension, sensorineural hearing loss, and optic atrophy. Paroxysmal dystonia may respond to benzodiazepines, whereas chronic dystonia may require botulinum toxin injections. Treatment of dystonia with levodopa may also be considered. Inadequate nutrition may require feeding therapy; placement of a feeding tube may be considered. Management of respiratory issues and apnea per intensivist and/or pulmonologist. Transition to adult care starting by approximately age 12 years; social work and family support. Surveillance: Evaluation with metabolic specialist and biochemical dietician, including assessment of total protein and valine intake, fasting plasma amino acids, blood total and free carnitine, acylcarnitine profile, blood lactate, and urine organic acids with frequency per metabolic specialist; measure sodium bicarbonate and blood lactate concentration with all viral illnesses or metabolic stressors. Measurement of growth parameters and assessment of nutritional status, safety of oral intake, developmental and educational needs, changes in neurologic manifestations, evidence of aspiration, respiratory insufficiency, sleep apnea, and family needs at each visit. Physical medicine and occupational and physical therapy assessment of mobility and self-help skills at each visit. Brain MRI and EEG as needed in those with new neurologic manifestations. At least annual echocardiogram and audiologic evaluation. Assess eye movements at each visit; dilated ophthalmology examination at ages six and 12 months and then annually. Agents/circumstances to avoid: Mitochondrial toxins (e.g., sodium valproate, prolonged propofol infusions); anesthesia should be used with caution; prevent catabolism; avoid lactate-containing agents; ketogenic diet may be poorly tolerated. Evaluation of relatives at risk: It is appropriate to evaluate at-risk newborns and apparently asymptomatic sibs of an affected individual to identify as early as possible those who would benefit from prompt institution of treatment. In an at-risk newborn, it is crucial to ensure metabolic stability by evaluating lactic acid concentration and blood gas. Urine organic acids and acylcarnitine profile may also be used as biochemical screening testing while waiting for ECHS1 molecular genetic testing results. ECHS1D is inherited in an autosomal recessive manner. In most instances, both parents of an affected child are heterozygous for an ECHS1 pathogenic variant. If the proband is compound heterozygous for an ECHS1 pathogenic variant and the ECHS1 c.489G>A variant, a parent may be homozygous for the c.489G>A variant (the c.489G>A variant does not cause disease when homozygous). If the proband has a chromosome 10q26 deletion involving ECHS1, a parent may carry a balanced rearrangement involving the 10q26 region. Rarely, a proband has one de novo pathogenic variant and one pathogenic variant inherited from a carrier parent. If both parents of an affected individual are known to be heterozygous for an ECHS1 pathogenic variant, each sib of an affected individual has at conception a 25% chance of inheriting biallelic pathogenic variants and being affected, a 50% chance of inheriting one pathogenic variant and being an asymptomatic carrier, and a 25% chance of inheriting neither of the familial pathogenic variants. If one parent is known to be heterozygous for an ECHS1 pathogenic variant and the other parent is known to be homozygous for the c.489G>A variant, each sib of an affected individual has at conception a 50% chance of inheriting biallelic variants and being affected and a 50% chance of inheriting only the c.489G>A variant and being an asymptomatic carrier. Once the ECHS1 pathogenic variants have been identified in an affected family member, carrier testing for relatives at risk and prenatal/preimplantation genetic testing are possible.

#2

Brain morphometry and cognition in late-onset glutaric aciduria type 1: scoping review and novel insights from a case report.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026 Mar 04

Glutaric Aciduria type I (GA1) is a rare autosomal recessive organic aciduria, with typical early-onset presentation, characterized by severe movement disorders with damage to the basal ganglia following an acute encephalopathic crisis. Late-onset (LO), milder forms have rarely been described. In LO patients, severe brain damage is frequently reported, including frontotemporal hypoplasia, brain atrophy, subependymal nodules and leukodystrophy. Cognitive impairment is sometimes described, often without formal psychometric assessment. This scoping review aims to synthesize the neuroradiological and neuropsychological features of all LO GA1 patients reported in the literature to date, divided in undiagnosed LO cases detected through selective screening and LO cases with onset of symptoms after 6 years of age. The following databases were used: PubMed, Embase and Medline. The search strategy abides by the PRISMA-ScR guidelines. Out of the 53 LO patients reviewed, extensive quantitative neuropsychological testing was reported in seven cases, while no brain morphometric analysis was performed. CASE REPORT. A novel case of a GA1 34-year-old Chinese woman identified through the neonatal screening of her healthy baby is described. Brain morphometric analysis showed diffused reduced volumes and cortical thinning, involving fronto-temporal areas and, to a lesser extent, the parieto-occipital regions. The neuropsychological assessment highlighted mild difficulties in verbal executive functions (inferential thinking) and phonological short-term memory. The present review and case report suggest that integrating neuroanatomical and neuropsychological investigations into clinical practice may allow a more refined characterization of GA1 patients, contributing to unveil the complex ethio-pathogenic mechanisms underlying the disease and monitor patients over time. The online version contains supplementary material available at 10.1007/s10072-026-08886-9.

#3

MDGA2 homozygous loss-of-function variants cause developmental and epileptic encephalopathy.

American journal of human genetics2026 Feb 05

MDGA2 encodes a membrane-associated protein that is critical for regulating glutamatergic synapse development, modulating neuroligins (Nlgns), and maintaining excitatory-inhibitory synaptic balance. While MDGA2 functions have been extensively studied in murine and cellular models, its association with human developmental disorders has yet to be established. Through exome sequencing, we identified seven distinct homozygous loss-of-function variants in MDGA2 in nine individuals from seven consanguineous families, all presenting with developmental and epileptic encephalopathy (DEE). Clinically, these individuals exhibited a consistent phenotype including infantile hypotonia, severe neurodevelopmental delay, intractable seizures, along with distinct dysmorphic features. Neuroimaging findings included delayed/incomplete myelination, early-onset brain atrophy, white-matter thinning, basal ganglia volume loss, and small hippocampi. Functional studies of three representative nonsense variants revealed impaired MDGA2 membrane trafficking, disrupted Nlgn1 interaction, and perturbed MDGA2-mediated excitatory synaptic functions in mammalian expression systems and cultured hippocampal neurons. Our findings support the involvement of MDGA2 in a subtype of autosomal-recessive DEE. This not only underscores a loss-of-function pathogenic mechanism but also highlights the previously unrecognized role of MDGA2 in human synaptic development and regulation, significantly expanding our understanding of the genetic architecture of DEEs. PPP1R21-related El-Hattab-Schmidts syndrome is predominantly a neurodevelopmental disorder characterized by global developmental delay, intellectual disability, hypotonia, and coarse facial features (highly arched and thick eyebrows, thick vermilion of the upper and lower lips, broad nasal bridge, and low-set ears). Ophthalmologic manifestations (strabismus, nystagmus, and optic atrophy) are common. Respiratory issues can include apnea, recurrent respiratory infections, and laryngomalacia. Cardiac manifestations (left ventricular hypertrophy or noncompaction, hypertrophic cardiomyopathy, and atrial septal defects), neurobehavioral features, seizures, and hepatomegaly have been reported. The diagnosis of PPP1R21-related El-Hattab-Schmidts syndrome is established in a proband by identification of biallelic pathogenic variants in PPP1R21 by molecular genetic testing. Treatment of manifestations: Developmental and educational services; feeding therapy; gastrostomy tube placement as needed for persistent feeding issues; treatment of refractive errors and strabismus per ophthalmologist; low vision services as needed; management of apnea and recurrent respiratory infections per pulmonologist; treatment of cardiac manifestations per cardiologist; standard treatment for epilepsy; transitional care planning; social work and family support. Surveillance: At each visit assess developmental progress, educational needs, mobility, self-help skills, growth parameters, nutritional status, safety of oral intake, and evidence of aspiration or respiratory insufficiency. Eye exam with frequency per treating ophthalmologist; respiratory examination with oxygen saturation at each visit; chest radiographs as indicated; echocardiogram annually; behavioral assessment at each visit; assessment of seizures at each visit; assessment of family and social work needs at each visit. PPP1R21-related El-Hattab-Schmidts syndrome is inherited in an autosomal recessive manner. If both parents are known to be heterozygous for a PPP1R21 pathogenic variant, each sib of an affected individual has at conception a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Once the PPP1R21 pathogenic variants have been identified in an affected family member, carrier testing for at-risk relatives and prenatal/preimplantation genetic testing are possible.

#4

Clinical and genetic findings of three patients with chorea-acanthocytosis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026 Jan 03

Chorea-acanthocytosis (ChAc) is a rare autosomal recessive neurodegenerative disorder caused by loss-of-function mutations in the VPS13A gene, encoding chorein, a protein involved in membrane homeostasis. Three clinical cases are described. The first, a 36-year-old man, presented with hyperkinetic movements, seizures, psychiatric symptoms, and caudate atrophy. Genetic testing revealed a homozygous splice-site mutation (c.9276-2 A> T) in VPS13A. The second case involved a patient with a milder phenotype but typical ChAc features, except epilepsy. A homozygous deletion which includes exons 69 and 70 was identified. This deletion is absent from control population databases and is described for the first time. Her younger brother, complaining of hyperCKemia and involuntary movements, was tested and identified as a homozygous carrier of the same deletion. ChAc should be considered in case of patients featuring a plethora of diffuse symptoms showing multisystemic involvement. Comprehensive genetic testing in patients with complex neurological symptoms might improve diagnostic accuracy and enhance knowledge of genotype-phenotype correlations in ChAc.

#5

From Neonatal Encephalopathy to Adult Survival: Revisiting the Natural History of D-Bifunctional Protein Deficiency in a Multicentre International Case Series.

Journal of inherited metabolic disease2026 Jan

D-bifunctional protein deficiency (DBP-D) is a rare autosomal recessive peroxisomal disorder caused by biallelic pathogenic HSD17B4 variants. Its clinical spectrum ranges from severe neonatal-onset encephalopathy to milder, juvenile-onset forms, but comprehensive data on long-term outcomes remain limited. We conducted a retrospective, multicentre review of 26 DBP-D patients managed at seven centres in the United Kingdom and Spain from 1982 to 2024. Clinical, biochemical, neuroimaging, neurophysiological, and genetic data were systematically collected. A literature review was performed to contextualize our findings. Most patients (92%) presented within the first 5 days of life with neonatal seizures and hypotonia. Mortality was high: 77% died before the age of 2 years and 20% between ages two and five. Notably, three patients survived beyond 5 years, including one with neonatal-onset now aged 19. Two others had infantile-juvenile presentations with hearing loss, ataxia, and cerebellar atrophy. While 68% of patients had elevated very long-chain fatty acids (VLCFAs), 32% had normal or mildly raised levels; all of these survived beyond 2 years. Pathogenic variants were distributed across all three HSD17B4 domains, with 14 novel alleles identified. Neuroimaging findings varied with severity: polymicrogyria and cysts predominated in neonatal-onset cases, while cerebellar atrophy was typical in later-onset survivors. This study expands the clinical and genetic landscape of DBP-D, demonstrating that survival into adulthood is possible and that normal or mildly elevated VLCFA levels are associated with milder phenotypes. Early molecular testing is essential in all suspected cases, even with normal VLCFAs, to guide diagnosis, prognosis, and long-term care.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 199

2026

A CACNA2D2-Related Recessive Form of Cerebellar Abiotrophy in Angus Cattle.

Animal genetics
2026

Case Report: Ataxia telangiectasia with severe hemorrhagic cystitis.

Frontiers in pediatrics
2026

To Do Or Not To Do: Therapeutic Hypothermia Treatment For An Infant With HIE And Prenatal Spinal Muscular Atrophy With Congenital Bone Fractures.

Journal of mother and child
2026

Brain morphometry and cognition in late-onset glutaric aciduria type 1: scoping review and novel insights from a case report.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

Neuro-Ophthalmic Presentation of Steroid 5a-Reductase Type 3 Congenital Disorder of Glycosylation: A Case of Monozygotic Twins.

Cureus
2026

Abnormal Newborn Screening Resembling Carnitine Palmitoyltransferase 1a Deficiency in Three Patients With COASY Protein Associated Neurodegeneration.

JIMD reports
2026

Variants in MTNAP1 underlie a neurodegenerative disorder by impairing mitochondrial stability.

NPJ genomic medicine
2026

[Motor neuron diseases from a radiological perspective : Focus on amyotrophic lateral sclerosis].

Radiologie (Heidelberg, Germany)
2025

Five-year disease-modifying therapeutic experience of 102 Chinese paediatric 5q-spinal muscular atrophy: a retrospective analysis.

Brain communications
2026

MDGA2 homozygous loss-of-function variants cause developmental and epileptic encephalopathy.

American journal of human genetics
2026

KCTD7-related progressive myoclonic epilepsy: Clinical and genetic characterization of six Indian patients and review of literature.

Seizure
2026

Allgrove syndrome with early neurodegeneration in a child: A case report from Syria.

Medicine
2025

Nasu-Hakola Disease Presenting as Rapidly Progressive Dementia With Seizures: A TREM2 Mutation Case Without Skeletal Involvement.

Cureus
2026

Clinical and genetic findings of three patients with chorea-acanthocytosis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

Elevated cerebrospinal fluid 2-Hydroxybutyric acid in two siblings with aspartate-glutamate carrier 1 deficiency.

Molecular genetics and metabolism
2025

A Novel Exon Duplication in the SACS Gene in Charlevoix-Saguenay Ataxia and a Summary of Polish Cases.

The application of clinical genetics
2025

A 10-Year-Old Boy With Ataxia-Telangiectasia: A Rare Case Report From Yemen.

Clinical medicine insights. Case reports
2025

Genetic and Epidemiological Aspects of Louis-Bar Syndrome Transmission: The Impact of Consanguineous Marriages on the Incidence of Hereditary Disorders.

Journal of mother and child
2025

IDEDNIK syndrome: a newly recognized rare genetic disorder caused by AP1S1 and AP1B1 mutations.

Frontiers in neurology
2026

From Neonatal Encephalopathy to Adult Survival: Revisiting the Natural History of D-Bifunctional Protein Deficiency in a Multicentre International Case Series.

Journal of inherited metabolic disease
2025

Systematic Phenotyping and Molecular Analysis of the Woozy Mouse: A Preclinical Model of Cerebellar Ataxia.

Molecular neurobiology
2025

Senior-Løken syndrome with IQCB1/NPHP5 mutation in an adult: a case report.

Journal of medical case reports
2026

Altered dimerization of certain riboflavin transporter 2 mutants: a possible source of UPR, altered calcium signalling and mitochondrial derangements in RTD2.

Archives of biochemistry and biophysics
2025

WDR81 Mutation in Two Siblings: A Case Report and Review of Literature.

Molecular syndromology
2025

Recessive variants in mitochondrial Complex I nuclear subunits are an underrated cause of optic atrophy.

Brain : a journal of neurology
2026

Variant Update on ASCC1 : Characterization of the First Homozygous Missense Variant Involved in Prenatal-Onset Spinal Muscular Atrophy With Congenital Bone Fractures 2.

American journal of medical genetics. Part A
2025

Discordant phenotype caused by TREX1 variant in siblings with Aicardi-Goutières syndrome.

Pediatric rheumatology online journal
2025

Severe Neurological Sequelae and Radiological Findings in a Lost-to-Follow-Up Case of Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome.

Cureus
2025

Expanding the clinical and genetic spectrum of GLUL-related developmental and epileptic encephalopathy.

Scientific reports
2025

A Novel HERC2 Variant in Two Siblings with Autosomal Recessive Intellectual Developmental Disorder-38 and Cardiomyopathy.

Molecular syndromology
2025

MFSD8-Related CLN7 Disease with Adult-Onset Cerebellar Ataxia: A Five-Patient Case Series.

Movement disorders clinical practice
2025

Pathogenicity of Mediator Complex Subunit 27 (MED27) in a Neurodevelopmental Disorder with Cerebellar Atrophy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2025

Diabetes and optic atrophy in a young adult: consider Wolfram syndrome.

Practical neurology
2025

Unravelling neurodegeneration with cerebral calcifications: Krabbe disease masquerading as Aicardi-Goutieres syndrome.

BMJ case reports
2025

Parkin, a key player in Parkinson's disease pathogenesis: A review.

International journal of biological macromolecules
2025

Spastic Ataxia Composite (SPAXCOM): A Scale to Evaluate the Progression of Subjects with Spasticity and Ataxia.

Movement disorders : official journal of the Movement Disorder Society
2025

Autosomal recessive frameshift variant broadens HECW2-related disease spectrum.

European journal of medical genetics
2025

AAV-based gene therapy ameliorates neurological deficits in a mouse model of childhood-onset neurodegeneration with cerebellar atrophy.

Molecular therapy : the journal of the American Society of Gene Therapy
2025

FBXO7 Pathogenic Variants in Early-Onset Parkinsonism: Insights from a Neuroimaging Perspective and Review of the Literature.

Movement disorders clinical practice
2025

Ciliopathy: Senior-Løken Syndrome.

Advances in experimental medicine and biology
2025

Infantile neuroaxonal dystrophy: Molecular mechanisms and pathogenesis of PLA2G6-associated neurodegeneration.

AIMS neuroscience
2025

Childhood-Onset Neurodegeneration With Progressive Microcephaly (CONPM) due to a DTYMK Homozygous Pathogenic Variant: Outlining the Phenotype of an Ultra-Rare Disease.

American journal of medical genetics. Part A
2025

Adolescent late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency manifesting with severe multi-organ failure: a case report.

Frontiers in pediatrics
2026

An Unstable ATG2A Variant Causes a Neurodegenerative Disorder via Impaired Autophagy and Proteotoxic Stress in Brain Atrophy.

Clinical genetics
2025

Malignant Infantile Osteopetrosis With Neurological and Hematological Complications: A Case Review.

Cureus
2025

Cerebrotendinous xanthomatosis: A rare neurodegenerative disorder with characteristic imaging findings.

Radiology case reports
2025

Identification and functional analysis of a novel TBC1D23 pathogenic variant in a Chinese family with pontocerebellar hypoplasia.

Human genomics
2025

Sarcoidosis-like Skin Lesions as the First Manifestation of Ataxia-Telangiectasia.

Children (Basel, Switzerland)
2025

PHARC (Polyneuropathy, Hearing Loss, Ataxia, Retinitis Pigmentosa and Cataract) - A Case Report and Clinical-Focused Literature Review.

Cerebellum (London, England)
2025

Biallelic Loss-of-Function Variant in MINPP1 Causes Pontocerebellar Hypoplasia with Characteristic Severe Neurodevelopmental Disorder.

International journal of molecular sciences
2025

A Hidden Diagnosis: Neurogenic Bladder Leading to Acute Kidney Failure in Wolfram Syndrome.

Cureus
2025

Beyond the homozygous paradigm: symptomatic partial biotinidase deficiency in a heterozygous child-first case report from Nepal.

BMC pediatrics
2025

Case Report: a novel homozygous ASNS variant in a Chinese female with severe microcephaly, encephalopathy and epilepsy.

Frontiers in neuroscience
2025

S100B Mitigates Cytoskeletal and Mitochondrial Alterations in a Glial Cell Model of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.

Molecular neurobiology
2025

Diagnostic journey and genetic analysis of a novel homozygous CYP2U1 mutation causing autosomal recessive spastic paraplegia type 56 (SPG56) in a consanguineous family.

BMC neurology
2025

Neonatal spinal muscular atrophy with brain magnetic resonance imaging hypersignal: a case report.

Frontiers in pediatrics
2025

Perioperative Care of a Child With Molybdenum Cofactor Deficiency.

Journal of medical cases
2025

Identification of a large homozygous RNF216 deletion in a Chinese patient with gordon holmes syndrome.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

In utero therapy for spinal muscular atrophy: closer to clinical translation.

Brain : a journal of neurology
2025

Child Neurology: TRAPPC4-Related Neurodevelopmental Disorder.

Neurology
2025

Compound heterozygosity of a De novo 16q24.1 deletion and missense mutation in COX4I1 leads to developmental regression, intellectual disability, and seizures.

Epilepsia open
2025

A de novo deletion underlying spinal muscular atrophy: implications for carrier testing and genetic counseling.

Human molecular genetics
2025

Knockout of the fcsk gene in zebrafish causes neurodevelopmental defects.

Zoological research
2024

Severe hyperhomocysteinemia due to MTHFR deficiency caused by a new mutation: A case report and literature review.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
2025

EEFSEC deficiency: A selenopathy with early-onset neurodegeneration.

American journal of human genetics
2025

Neuropsychological profile of POLR3A-related spastic ataxia.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2024

Novel PNPLA8 variants associated with primary ovarian insufficiency, tremors, cerebellar ataxia and limb weakness: a case report and literature review.

Journal of neurology
2024

Novel pathogenic ATM mutation with ataxia-telangiectasia in a Chinese family.

Frontiers in genetics
2025

The correlation of intracranial parenchymal calcium score and the severity of neurological clinical presentation in carbonic anhydrase deficiency type 2.

Brain &amp; development
2024

The ataxia-telangiectasia disease protein ATM controls vesicular protein secretion via CHGA and microtubule dynamics via CRMP5.

Neurobiology of disease
2024

Intragenic duplication disrupting the reading frame of MFSD8 in Small Swiss Hounds with neuronal ceroid lipofuscinosis.

Animal genetics
2024

Perspectives in the investigation of Cockayne syndrome group B neurological disease: the utility of patient-derived brain organoid models.

Journal of Zhejiang University. Science. B
2024

EAST (Epilepsy, Ataxia, Sensorineural Hearing Loss, and Renal Tubulopathy) Syndrome: A Rare Association Between Brain, Ear, and Kidney.

Cureus
2024

Recent Advance in Disease Modifying Therapies for Spinal Muscular Atrophy.

Acta neurologica Taiwanica
2024

De Novo GRID2 Variant as a Cause of Ataxia with Oculomotor Apraxia and Alpha-Fetoprotein Elevation.

Cerebellum (London, England)
2025

Obsessive-compulsive disorder as a first manifestation of Ataxia with Oculomotor Apraxia type 2 due to a novel mutation of SETX gene.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Biallelic PTPMT1 variants disrupt cardiolipin metabolism and lead to a neurodevelopmental syndrome.

Brain : a journal of neurology
2025

Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders.

Genetics in medicine : official journal of the American College of Medical Genetics
2024

[Rare forms of autosomal recessive spinocerebellar ataxia associated with mutations in the ANO10 (ATX-ANO10) and SYNE1 (ATX-SYNE1) genes].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
2024

Identification of biallelic mutations in MCM3AP and comprehensive literature analysis.

Frontiers in genetics
2024

Wolfram Syndrome 1: A Neuropsychiatric Perspective on a Rare Disease.

Genes
2024

Mevalonic Aciduria in a Pediatric Patient: A Case Report and Literature Review of Neuroimaging Findings.

Cureus
2025

Novel fetal phenotype of TAF8 deficiency.

European journal of human genetics : EJHG
2024

Homozygous Paternally Inherited ASPA Variant in a Patient with Canavan Disease.

Molecular syndromology
2024

Wolfram Syndrome Type I Case Report and Review-Focus on Early Diagnosis and Genetic Variants.

Medicina (Kaunas, Lithuania)
2024

Clinical, genetic, and neuroimaging profiles of autosomal recessive spinocerebellar ataxia type 4 caused by novel VPS13D variants in Chinese.

American journal of medical genetics. Part A
2024

Clinical and genetic variability among Bulgarian patients with autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Molecular genetics &amp; genomic medicine
2024

Human organoid model of pontocerebellar hypoplasia 2a recapitulates brain region-specific size differences.

Disease models &amp; mechanisms
2024

Long-term impact of nusinersen on motor and electrophysiological outcomes in adolescent and adult spinal muscular atrophy: insights from a multicenter retrospective study.

Journal of neurology
2024

Adult-Onset Neuropsychiatric Symptoms as the Presenting Feature of Xeroderma Pigmentosum Group G: A Report of a Rare Case.

Cureus
2024

Sequential Presentation of Obsessive-Compulsive Disorder and Narcolepsy in a 10-Year-Old Girl With Wolfram Syndrome 1.

The Journal of nervous and mental disease
2024

Unexpected complexity in the molecular diagnosis of spastic paraplegia 11.

Molecular genetics &amp; genomic medicine
2024

Case report: Misdiagnosed orolingual dyskinesia as a consequence of seizures in a chorea-acanthocytosis patient with a novel VPS13A variation from a family with consanguineous marriage.

Frontiers in neurology
2024

An MRI evaluation of white matter involvement in paradigmatic forms of spastic ataxia: results from the multi-center PROSPAX study.

Journal of neurology
2024

Cognitive Decline and Other Late-Stage Neurologic Complications in Cockayne Syndrome.

Neurology. Clinical practice
2024

FADD gene pathogenic variants causing recurrent febrile infection-related epilepsy syndrome: Case report and literature review.

Epilepsia
2024

Emerging variants, unique phenotypes, and transcriptomic signatures: an integrated study of COASY-associated diseases.

Annals of clinical and translational neurology
2024

Altered mitochondrial function in fibroblast cell lines derived from disease carriers of spinal muscular atrophy.

Communications medicine
2024

Clinical and neurogenetic characterisation of autosomal recessive RBL2-associated progressive neurodevelopmental disorder.

medRxiv : the preprint server for health sciences
2024

Genetic and clinical profile of 15 Chinese families with GDAP1-related Charcot-Marie-Tooth disease and identification of H256R as a frequent mutation.

Journal of the peripheral nervous system : JPNS
2024

Adolescent-onset epilepsy and deterioration associated with CAD deficiency: A case report.

Brain &amp; development
2024

A rare inherited homozygous missense variant in PLA2G6 influences susceptibility to infantile neuroaxonal dystrophy: a case report.

Translational pediatrics
2024

Clinical and Molecular Spectrum of Autosomal Recessive CA8-Related Cerebellar Ataxia.

Movement disorders : official journal of the Movement Disorder Society
2024

Ataxia telangiectasia: a rare case report from Nepal.

Annals of medicine and surgery (2012)
2024

Neurodevelopmental disorder in a patient with HMBS and SCN3A variants-A possibly blended phenotype further delineating autosomal recessive HMBS related disease.

American journal of medical genetics. Part A
2024

Incidental Finding of MEGDEL Syndrome at a Tertiary Care Center in Saudi Arabia.

Cureus
2024

A novel variant in ASNS gene responsible for syndromic intellectual disability and microcephaly: Case report and literature review.

Molecular genetics &amp; genomic medicine
2024

RTN2 deficiency results in an autosomal recessive distal motor neuropathy with lower limb spasticity.

Brain : a journal of neurology
2024

No significant sex differences in incidence or phenotype for the SMNΔ7 mouse model of spinal muscular atrophy.

Neuromuscular disorders : NMD
2024

Expanding the genetic and phenotypic spectrum of TRAPPC9 and MID2-related neurodevelopmental disabilities: report of two novel mutations, 3D-modelling, and molecular docking studies.

Journal of human genetics
2024

Spinal Muscular Atrophy With Severe Hyperlordosis: A Case Report.

Cureus
2024

A case report of molybdenum cofactor deficiency type A: the first case diagnosed in Syria.

Annals of medicine and surgery (2012)
2024

Expanded clinical phenotype and untargeted metabolomics analysis in RARS2-related mitochondrial disorder: a case report.

BMC neurology
2024

4-aminopyridine improves evoked potentials and ambulation in the taiep rat: A model of hypomyelination with atrophy of basal ganglia and cerebellum.

PloS one
2024

Long-term follow-up of an attenuated presentation of NAXE-related disease, a potentially actionable neurometabolic disease: a case report.

Frontiers in neurology
2024

Promoting expression in gene therapy: more is not always better.

EMBO molecular medicine
2024

Late Presentation of β-Thalassemia Major Patient With Left Hemiparesis: A Case Report.

Cureus
2024

Hereditary spastic paraplegia type 35 in a Turkish girl with fatty acid hydroxylase-associated neurodegeneration.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2023

Biallelic variants in HTRA2 cause 3-methylglutaconic aciduria mitochondrial disorder: case report and literature review.

Frontiers in genetics
2024

Neuroimaging features in Wolfram syndrome type 1.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2023

Spinal muscular atrophy in Ghanaian children confirmed by molecular genetic testing: a case series.

The Pan African medical journal
2024

Ophthalmic manifestations of biotinidase deficiency: report of a case and review of literature.

Ophthalmic genetics
2024

Behavioral Management of Respiratory/Phonatory Dysfunction for Dysarthria Associated With Neurodegenerative Disease: A Systematic Review.

American journal of speech-language pathology
2024

[Congenital Myasthenic Syndromes].

Brain and nerve = Shinkei kenkyu no shinpo
2024

Clinical, Imaging, Genetic, and Disease Course Characteristics in Patients With GM2 Gangliosidosis: Beyond Age of Onset.

Neurology
2024

Long term peripheral AAV9-SMN gene therapy promotes survival in a mouse model of spinal muscular atrophy.

Human molecular genetics
2023

Novel mutation in RPGRIP1L gene causing Joubert syndrome: A case report.

Medicine
2024

Clinical and genetic analysis of infants with pontocerebellar hypoplasia type 6 caused by RARS2 variations.

Epilepsia open
2023

Wolfram Syndrome: A Curious Case of Repetitive Loss of Consciousness.

Cureus
2023

Novel LAGE3 Pathogenic Variants Combined with TRPC6 and NUP160 Variants in Galloway-Mowat Syndrome: A Case Report.

Case reports in nephrology and dialysis
2024

Widening the clinical, radiological and genetic spectrum of autosomal recessive ataxia of Charlevoix-Saguenay in Indian patients.

Acta neurologica Belgica
2024

The identification of a novel mutation (p.I223fs) in WRN associated with Werner syndrome.

Endocrine
2024

Severe Neurodevelopmental Disorder in Autosomal Recessive Spinocerebellar Ataxia 13 (SCAR13) Caused by Two Novel Frameshift Variants in GRM1.

Cerebellum (London, England)
2023

In Cerebellar Atrophy of 12-Month-Old ATM-Null Mice, Transcriptome Upregulations Concern Most Neurotransmission and Neuropeptide Pathways, While Downregulations Affect Prominently Itpr1, Usp2 and Non-Coding RNA.

Cells
2024

Homozygous MFN2 variants causing severe antenatal encephalopathy with clumped mitochondria.

Brain : a journal of neurology
2023

Lunapark deficiency leads to an autosomal recessive neurodevelopmental phenotype with a degenerative course, epilepsy and distinct brain anomalies.

Brain communications
2023

Novel heterozygous VPS13A pathogenic variants in chorea-neuroacanthocytosis: a case report.

BMC neurology
2023

Sjogren-Larsson syndrome brain volumetric reductions demonstrated with an automated software.

Arquivos de neuro-psiquiatria
2023

Genomics of Wolfram Syndrome 1 (WFS1).

Biomolecules
2024

Late-onset Tay-Sachs disease presenting with a neuromuscular phenotype-a case series.

European journal of neurology
2023

Novel CWF19L1 mutations in patients with spinocerebellar ataxia, autosomal recessive 17.

Journal of human genetics
2023

Preliminary insights into RNA in CSF of pediatric SMA patients after 6 months of nusinersen.

Biology direct
2023

Severe KIDAR syndrome caused by deletion in the AP1B1 gene: Report of a teenage patient and systematic review of the literature.

European journal of medical genetics
2023

USH2A variants causing retinitis pigmentosa or Usher syndrome provoke differential retinal phenotypes in disease-specific organoids.

HGG advances
2023

Autosomal Dominant MPAN: Mosaicism Expands the Clinical Spectrum to Atypical Late-Onset Phenotypes.

Movement disorders : official journal of the Movement Disorder Society
2023

Expanding the allelic spectrum of ELOVL4-related autosomal recessive neuro-ichthyosis.

Molecular genetics &amp; genomic medicine
2023

Case report: Birk-Landau-Perez syndrome linked to the SLC30A9 gene-identification of additional cases and expansion of the phenotypic spectrum.

Frontiers in genetics
2023

Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy.

Journal of clinical medicine
2023

Progressive myoclonic epilepsy type 1 (EPM1) patients present with abnormal 1H MRS brain metabolic profiles associated with cognitive function.

NeuroImage. Clinical
2024

Persistent basal ganglia involvement in aminoacylase-1 deficiency: expanding imaging findings and review of literature.

Irish journal of medical science
2023

Biallelic MED27 variants lead to variable ponto-cerebello-lental degeneration with movement disorders.

Brain : a journal of neurology
2023

Neuro-Ophthalmologic Variability in Presentation of Genetically Confirmed Wolfram Syndrome: A Case Series and Review.

Brain sciences
2023

Compound heterozygous variants in MAPK8IP3 were detected in severe congenital hypotonia mimicking lethal spinal muscular atrophy.

American journal of medical genetics. Part A
2023

MRI characteristics due to gene mutations in a Chinese pedigree with Lafora disease.

Molecular genetics &amp; genomic medicine
2023

[MOH SCREENING FOR TBCD IN COCHIN JEWS: COLLABORATION BETWEEN MEDICAL, RESEARCH AND COMMUNITY MEMBERS IN ACHIEVING PUBLIC HEALTH GOALS].

Harefuah
2024

Expanding the Spectrum of Stress-Induced Childhood-Onset Neurodegeneration with Variable Ataxia and Seizures (CONDSIAS).

Cerebellum (London, England)
2023

Advanced Early-Onset Fahr's Disease: A Case Report.

Cureus
2023

Biomarkers for predicting disease course in Sanfilippo syndrome: An urgent unmet need in childhood-onset dementia.

Journal of neurochemistry
2023

Brain abnormalities, neurodegeneration, and dysosteosclerosis (BANDDOS): new cases, systematic literature review, and associations with CSF1R-ALSP.

Orphanet journal of rare diseases
2023

A novel biallelic frameshift variant in C2orf69 causing developmental regression, seizures, microcephaly, autistic features, and hypertonia.

American journal of medical genetics. Part A
2023

A case of Sandhoff disease caused by a novel β-hexosaminidase B (HEXB) mutation c.118delG (p.A40fs*24): A case report from China.

Medicine
2023

PTRH2 Gene Variants: Recent Review of the Phenotypic Features and Their Bioinformatics Analysis.

Genes
2023

Expanding the Knowledge of KIF1A-Dependent Disorders to a Group of Polish Patients.

Genes
2023

Foveoschisis associated with gyrate atrophy in ornithine aminotransferase deficiency: A case report.

Photodiagnosis and photodynamic therapy
2023

[Treatment of Spinal Muscular Atrophy].

Brain and nerve = Shinkei kenkyu no shinpo
2023

Ketogenic diet-responsive drug-resistant epilepsy in a case of asparagine synthetase deficiency with a novel compound heterozygous missense variant.

Clinical neurology and neurosurgery
2023

Novel LSS variants in alopecia and intellectual disability syndrome: New case report and clinical spectrum of LSS-related rare disease traits.

Clinical genetics
2023

Autosomal recessive Leber hereditary optic neuropathy, a new neuro-ophthalmo-genetic paradigm.

Brain : a journal of neurology
2023

Shift from severe hypotension to salt-dependent hypertension in a child with autosomal recessive polycystic kidney disease after bilateral nephrectomies: a case report.

BMC nephrology
2023

A Biallelic Truncating Variant in the TPR Domain of GEMIN5 Associated with Intellectual Disability and Cerebral Atrophy.

Genes
2022

Clinical Manifestations Associated with the Domain-Containing Protein 2 Gene Mutation in an Iranian Family with Spastic Paraplegia 54.

Neuro-degenerative diseases
2023

[Clinical characteristics and genetic analysis of a case with adult neuronal ceroid lipofuscinosis type 7 due to variant of MFSD8 gene].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2023

Complex clinical manifestations and new insights in RNA sequencing of children with diabetes and WFS1 variants.

Frontiers in endocrinology
2022

[Progressive myoclonic epilepsy in the department of neurology of the University Teaching hospital Point "G"].

Le Mali medical
2023

NOTCH2NLC GGC Repeat Expansion in Patients With Vascular Leukoencephalopathy.

Stroke
2023

A novel homozygous synonymous splicing variant in SELENOI gene causes spastic paraplegia 81.

The journal of gene medicine
2023

Cynomolgus macaque model of neuronal ceroid lipofuscinosis type 2 disease.

Experimental neurology
2023

ALG11-CDG: novel variant and review of the literature.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2023

Linear Diagnostic Procedure Elicited by Clinical Genetics and Validated by mRNA Analysis in Neuronal Ceroid Lipofuscinosis 7 Associated with a Novel Non-Canonical Splice Site Variant in MFSD8.

Genes
2023

Case report: Variants in the ERCC4 gene as a rare cause of cerebellar ataxia with chorea.

Frontiers in genetics
2023

Case Report: A novel mutation in WFS1 gene (c.1756G>A p.A586T) is responsible for early clinical features of cognitive impairment and recurrent ischemic stroke.

Frontiers in genetics
2023

Mitochondrial optic neuropathies.

Handbook of clinical neurology
2023

Retinal Findings in Haemorrhagic Destruction of the Brain, Subependymal Calcification, and Congenital Cataracts (HDBSCC): Case Report and Review.

Neuro-ophthalmology (Aeolus Press)
2023

WWOX developmental and epileptic encephalopathy: Understanding the epileptology and the mortality risk.

Epilepsia
2022

β-cyclodextrin based nano gene delivery using pharmaceutical applications to treat Wolfram syndrome.

Therapeutic delivery
2023

The neuroimaging spectrum of SLC13A5 related developmental and epileptic encephalopathy.

Seizure
2022

Novel compound heterozygous mutations of MTHFR Gene in a Chinese family with homocystinuria due to MTHFR deficiency.

BMC medical genomics
2023

Topological Structural Brain Connectivity Alterations in Aspartylglucosaminuria: A Case-Control Study.

AJNR. American journal of neuroradiology
2023

Caregiver Burden of Spinal Muscular Atrophy: A Systematic Review.

PharmacoEconomics
2022

Spinocerebellar ataxia type 17-digenic TBP/STUB1 disease: neuropathologic features of an autopsied patient.

Acta neuropathologica communications
2022

Brain and spine MRI findings in children presenting with TMCO1 mutation.

BJR case reports
2023

Early onset hereditary neuronopathies: an update on non-5q motor neuron diseases.

Brain : a journal of neurology
2022

A Novel Mutation in the NAGLU (N-Acetyl-Alpha-Glucosaminidase) Gene Associated With Mucopolysaccharidosis Type III-B in a Saudi Girl.

Cureus
2023

Evaluation of Cerebellar Ataxic Patients.

Neurologic clinics
2023

The top 10 most frequently involved genes in hereditary optic neuropathies in 2186 probands.

Brain : a journal of neurology
2023

The clinical and molecular spectrum of ZFYVE26-associated hereditary spastic paraplegia: SPG15.

Brain : a journal of neurology
2022

Five patients with spinal muscular atrophy-progressive myoclonic epilepsy (SMA-PME): a novel pathogenic variant, treatment and review of the literature.

Neuromuscular disorders : NMD
2022

Clinical and genetic characterization of a Taiwanese cohort with spastic paraparesis combined with cerebellar involvement.

Frontiers in neurology
2022

A Novel Missense Mutation in ERCC8 Co-Segregates with Cerebellar Ataxia in a Consanguineous Pakistani Family.

Cells

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Atrofia cerebral autossômica recessiva.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Atrofia cerebral autossômica recessiva

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Case Report: Ataxia telangiectasia with severe hemorrhagic cystitis.
    Frontiers in pediatrics· 2026· PMID 41837192mais citado
  2. Brain morphometry and cognition in late-onset glutaric aciduria type 1: scoping review and novel insights from a case report.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology· 2026· PMID 41779049mais citado
  3. MDGA2 homozygous loss-of-function variants cause developmental and epileptic encephalopathy.
    American journal of human genetics· 2026· PMID 41570816mais citado
  4. Clinical and genetic findings of three patients with chorea-acanthocytosis.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology· 2026· PMID 41484683mais citado
  5. From Neonatal Encephalopathy to Adult Survival: Revisiting the Natural History of D-Bifunctional Protein Deficiency in a Multicentre International Case Series.
    Journal of inherited metabolic disease· 2026· PMID 41367148mais citado
  6. An Ultra-Rare Mixed Phenotype with Combined AP-4 and ERF Mutations: The First Report in a Pediatric Patient and a Literature Review.
    Genes (Basel)· 2024· PMID 38674371recente
  7. Report of two pedigrees with heterozygous HTRA1 variants-related cerebral small vessel disease and literature review.
    Mol Genet Genomic Med· 2022· PMID 35946346recente
  8. Case Report: Clinical Features of Childhood Leukoencephalopathy With Cerebral Calcifications and Cysts Due to SNORD118 Variants.
    Front Neurol· 2021· PMID 34220662recente
  9. Leukoencephalopathy with calcifications and cysts (LCC): 5 cases and literature review.
    Rev Neurol (Paris)· 2020· PMID 31521395recente
  10. Treatment of Leukoencephalopathy With Calcifications and Cysts With Bevacizumab.
    Pediatr Neurol· 2017· PMID 28424147recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:363969(Orphanet)
  2. MONDO:0018218(MONDO)
  3. GARD:21560(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q55346031(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Atrofia cerebral autossômica recessiva
Compêndio · Raras BR

Atrofia cerebral autossômica recessiva

ORPHA:363969 · MONDO:0018218
Prevalência
<1 / 1 000 000
Casos
4 casos conhecidos
Herança
Autosomal recessive
CID-10
G31.8 · Outras doenças degenerativas especificadas do sistema nervoso
Início
Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C4755252
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades